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ABSTRACT 
Background: Monoamniotic twins are at increased risk of perinatal complications. Perinatal 
mortality has been reported to be high, primarily related to cord entanglement.
 
International 
guidelines made no recommendation regarding whether these women should be managed in the 
hospital or can be safely managed in outpatient settings. Moreover, timing of planned delivery in 
these women is also a subject of debate.  
Objective: To compare the perinatal outcomes of inpatient versus outpatient fetal surveillance 
approaches employed among 22 participating study centers; and to calculate the fetal and neonatal 
death rate according to gestational age in non-anomalous monoamniotic twins from 26 weeks’ 
gestation. 
Study design: The MONOMONO study was a multinational cohort study. Clinical records of all 
consecutive women with monochorionic monoamniotic twin pregnancies, who were referred to 22 
university hospitals in Italy, the United States, the United Kingdom, and Spain, from January 2010 
to January 2017, were included in the study. Only non-anomalous uncomplicated monoamniotic 
twins with both fetuses alive at 26 0/7 weeks were included in the study. Management of 
monoamniotic twins was different in the different included centers. In 10 centers all monoamniotic 
twins were routinely managed inpatient. In 12 centers all monoamniotic twins were routinely 
managed as outpatients. The primary outcome was intrauterine fetal death in the inpatient versus 
outpatient group. We also planned to assess the fetal death rate and the neonatal death rate 
according to gestational age per 1-week interval. Outcomes were presented as odds ratio (OR) with 
the 95% of confidence interval (CI). In addition to the standard logistic regression analysis, we used 
a generalized mixed model approach, with twin pair as the cluster unit. This model was used 
because the outcomes of each twin were not independent of the co-twin. 
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Results: 195 consecutive pregnant women with non-anomalous uncomplicated monoamniotic 
twin gestations (390 fetuses) were included. Of them, 75 (38.5%) were managed as inpatients 
and 120 (61.5%) were managed as outpatients. The overall perinatal loss rate was 10.8% 
(42/390) with the peak fetal death rate occurring at 29 weeks gestation (15/348, 4.3%). There 
was no significant difference in mean gestation age at delivery (31 weeks), birth weight (~1.6 
kg), or emergency delivery rate between the inpatient and outpatient surveillance groups. There 
was no statistically significant difference in fetal death rates between inpatient surveillance 
protocols commencing from around 26 weeks compared with outpatient surveillance protocols 
from 30 weeks (3.3% vs 10.8%; adjusted OR 0.21, 95% CI 0.04 to 1.17). Maternal LOS in the 
hospital was 42.1 days in the inpatient group, and 7.4 days in the outpatient group (MD 34.70 
days, 95% CI 31.31 to 38.09). From 32 0/7 to 36 6/7 weeks, no fetal or neonatal death in either 
group was recorded. 46 fetuses delivered after 34 0/7 weeks, and none of them died in utero or 
within the first 28 days of life. 
Conclusion: In uncomplicated monoamniotic twins, when compared with outpatient management, 
inpatient surveillance is associated with similar fetal mortality. After 31 6/7 weeks there were no 
intrauterine fetal deaths or neonatal deaths even up to 36 6/7 weeks. 
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INTRODUCTION 
Monochorionic monoamniotic twinning accounts for about 1-2% of monozygotic twin pregnancies 
worldwide.
1-6
 Monoamniotic twins are at increased risk of perinatal complications compared to 
monochorionic diamniotic and dichorionic twin pregnancies.
3-5
 Perinatal mortality has been 
reported as being high in monoamniotic twins, primarily related to cord entanglement.
5 
Early and 
mid-pregnancy loss before 26 weeks seems to be mainly correlated with Twin Reversed Arterial 
Perfusion Sequence (TRAP) sequence, conjoined twins and major congenital anomalies, with a rate 
of these complications as high as 60% in studies evaluating high-risk referred populations.
5,7
 
Regarding late pregnancy loss after 26 weeks, the largest review on monoamniotic twins, including 
60 studies with 133 non-conjoined twin monoamniotic pregnancies, reported a non-anomalous 
perinatal mortality rate of about 20% with a significant rise in mortality after 32 weeks of 
gestation.
7,8-10
 These data are often used to justify planned preterm delivery from 32 weeks in 
otherwise uncomplicated monoamniotic twins.
5,9
 However, robust data on which decision on timing 
of delivery can be based are missing. 
Inpatient management from viability until delivery has been reported for monoamniotic twin 
pregnancies.
5
 The American College of Obstetricians and Gynecologists (ACOG), and the Society 
for Maternal Fetal Medicine (SMFM) made no recommendation regarding whether these women 
should be managed in the hospital or can be safely managed in outpatient settings, and concluded 
that “the optimal management of these patients remains uncertain.”
 9
 
Objective 
The aim of this study was to compare the perinatal outcomes of inpatient versus outpatient fetal 
surveillance approaches employed among 22 participating study centers; and to calculate the fetal 
and neonatal death rate according to gestational age in non-anomalous monoamniotic twins of at 
least 26 weeks gestation. 
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MATERIALS and METHODS 
Study design and participants 
This was a multinational, retrospective, cohort study. Clinical records of pregnant women with 
monochorionic monoamniotic twin pregnancies who were referred to 22 university hospitals in 
Italy, United States, United Kingdom, Spain (See Acknowledgments section for complete list of 
participating hospitals), from January 2010 to January 2017 were collected in a dedicated merged 
database and included in the study. Only women with confirmed pathology diagnosis of 
monoamnionicity after delivery were included.  
All variables reported were collected on all of the subjects included in this study. Inclusion criteria 
were the attainment of at least 26 0/7 weeks with both fetuses alive, and confirmation of 
monoamnioticity at delivery and/or by pathologic examination of the placenta. Only uncomplicated 
monoamniotic twin pregnancies were included. Exclusion criteria were pseudomonoamnioticity 
(the iatrogenic creation of a single amniotic space because of an invasive procedure), conjoined 
twins, major fetal abnormality, intrauterine growth restriction (IUGR) or selective IUGR (sIUGR) 
(i.e. ultrasound estimated fetal weight <10
th
 centile of one or both fetuses), twin-to-twin transfusion 
syndrome, TRAP sequence, acardiac twins, spontaneous miscarriage before 26 weeks, and higher-
order multiple pregnancies. Women who underwent selective reduction were also excluded. 
Therefore, all women included in the study were non-anomalous uncomplicated monoamniotic 
twins who reached viability for both fetuses at 26 weeks.  
In 10 centers all monoamniotic twins were routinely managed as inpatient. In 12 centers all 
monoamniotic twins were routinely managed as outpatient (Table 1).  
In cases of outpatient care, frequent follow-up was employed, with regular assessment of fetal 
wellbeing with ultrasound fetal growth (fetal biometry for both twins, and amniotic fluid volume 
with deepest vertical pocket) every 3 weeks, ultrasound Doppler (umbilical artery Doppler, and 
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middle cerebral artery peak systolic velocity, for both twins) every 2 weeks,
10
 and nonstress tests 
(NST), usually once a week with either standard NST or computerized cardiotocography (CTG). 
Women managed as inpatients were admitted from 26 0/7 – 27 6/7 weeks until delivery. In this 
group women were managed with two or three times daily NST, ultrasound fetal growth every 3 
weeks, and ultrasound Doppler every 2 weeks (Table 1).
10
 None of the included centers performed 
continuous fetal heart rate monitoring. 
Women in the inpatient group (study group) were all admitted, and delivered in one admission. For 
women included in the outpatient group (comparison group) who had one or more admission, total 
length of stay was calculated.  
In both groups delivery was scheduled via planned cesarean delivery usually at 32 0/7 – 34 6/7 
weeks according to local protocol and at provider discretion (Table 1).
9,11
 Indication for earlier 
delivery was recorded. Antenatal corticosteroids for fetal lung maturation were offered before 
planned cesarean delivery. 
Transvaginal ultrasound cervical length screening for prevention of preterm birth was not routinely 
performed in either group, given that lack of treatment for twins with short cervix.
12-16
  
Outcomes 
Primary and secondary outcomes were compared between the inpatient and outpatient groups.  
The primary outcome was intrauterine fetal death (i.e. stillbirth) after 26 weeks. The secondary 
outcomes were gestational age at delivery, total antenatal maternal length of stay (LOS) in the 
hospital, indication for delivery, birth weight, LOS in neonatal intensive care unit (NICU) (days in 
NICU from admission in NICU to discharge from the NICU), neonatal death (i.e. death of a live-
born baby within the first 28 days of life), and perinatal death (i.e. either fetal or neonatal death).  
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We also planned to assess the fetal and neonatal death rate according to gestational age per 1-week 
interval. This secondary analysis was performed separately for the inpatient and outpatient group. 
Statistical analysis 
Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) v. 19.0 
(IBM Inc., Armonk, NY, USA). Data are shown as means ± standard deviation (SD), or as medians 
(range), or as numbers (percentage). Univariate comparisons of dichotomous data were performed 
with the use of the chi-square with continuity correction. Comparisons between groups were 
performed with the use of the T-test to test group means with SD by assuming equal within-group 
variances, and with the use of the Mann-Whitney U test to test group medians with range. Primary 
and secondary outcomes were presented as odds ratio (OR) with the 95% of confidence interval 
(CI).
18
 This analysis is a univariate analysis treating each fetus as independent unit. In addition to 
the standard logistic regression analysis, we used a generalized mixed model approach, with twin 
pair as the cluster unit. This model was used because the outcomes of each twin were not 
independent of the co-twin.  
We calculated two sided p-values. A p-value <0.05 was considered to indicate statistical 
significance.
19
 This study was reported following the STROBE guidelines.
20 
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RESULTS 
Characteristics of the women 
195 consecutive women with non-anomalous uncomplicated monoamniotic twin gestations 
(390 fetuses), with both fetuses alive at 26 weeks, were included in this study (Figure 1). Of 
them, 75 women (38.5%) were managed as inpatients and 120 women (61.5%) as outpatients. 
Inpatient and outpatient management policies were highly variable between the included 
centers. Inpatient monitoring usually started at about 26 weeks of gestation, whereas 
monitoring was instituted usually after 30 weeks gestation in the outpatient group (Table 1). 
The two groups were similar in terms of demographic characteristics. The mean maternal age 
was about 30 years in both groups. One woman in the inpatient group and one in the outpatient 
group had a history of stillbirth in a prior pregnancy (Table 2). 
Primary analysis 
When analyzed using a standard logistic regression analysis, non-anomalous uncomplicated 
monoamniotic twin pregnancies managed inpatient from 26 weeks to delivery had a 
significantly lower rate of intrauterine fetal death (3.3% vs 10.8%; OR 0.28, 95% CI 0.11 to 
0.76), perinatal death (4.0% vs 15.0%; OR 0.24, 95% CI 0.10 to 0.58), and shorter length of 
NICU stay by approximately 16 days (MD -15.90 days, 95% CI -23.55 to -8.25). Mean 
maternal LOS in the hospital was 42.1 days in the inpatient group, and 7.4 days in the 
outpatient group (MD 34.70 days, 95% CI 31.36 to 38.04) (Table 3).  
When analyzed using a generalized mixed model approach, as compared to pregnancies with 
outpatient management, non-anomalous uncomplicated monoamniotic twin pregnancies with 
inpatient management had similar rates of intrauterine fetal death (raw rates: 3.3% vs 10.8%; 
adjusted OR 0.21, 95% CI 0.04 to 1.17; Table 4). 
Indications for early delivery are shown in Table 5. 70.7% of the women in the inpatient group 
and 68.3% of the women in the outpatient group delivered via scheduled cesarean delivery on 
the planned date. 
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Secondary analysis 
The overall fetal, neonatal, and perinatal death rates in our cohort were 7.9% (31/390), 2.8% 
(11/390), and 10.8% (42/390), respectively (Table 3, Table 6, Table S1, Table S2). Details of fetal, 
neonatal, and perinatal deaths according to gestational age at delivery are shown in Table 6, Table 
S1, and Table S2.  
The intrauterine fetal death rate per 1-week interval ranged from 0% to 3.6%. The highest weekly 
intrauterine fetal death rate was between 29 0/7 – 29 6/7 weeks, in both the inpatient (2.0% rate) 
and outpatient group (6.0% rate).  
From 32 0/7 to 35 6/7 weeks, no fetal or neonatal death occurred in either group (Table 6, Table 
S1), with 0/46 perinatal death between 34 0/7 – 34 6/7 weeks, 0/20 between 35 0/7 – 35 6/7 weeks, 
and 0/10 between 36 0/7 – 36 6/7 (Table S2).  
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DISCUSSION 
Main findings 
Monoamniotic twins are at greatly increased risk of neonatal death because of umbilical cord 
entanglement, in addition to the other risks of monochorionicity and twin pregnancy in general. 
These risks in the past have been associated with a loss rate as high as 70%.
5,14-21
 In this cohort of 
390 uncomplicated monoamniotic fetuses, the overall rate of perinatal death was 10.8%.  
Using the standard logistic regression analysis, this rate was significantly lower in the women 
managed inpatient compared to those managed outpatient. We also reported an improvement in 
neonatal outcomes, with shorter LOS in NICU associated with elective admission for inpatient 
monitoring. When analyzed using a generalized mixed model approach, inpatient management had 
similar rates of intrauterine fetal death compared to the outpatient management. The first analysis 
was a univariate analysis treating each fetus as independent unit. Therefore, our study showed that 
when treating each fetal death as an independent event, there did appear to be a statistically 
significant difference in inpatient vs outpatient groups. However, because second twins have an 
increased risk of fetal death after first twin death, this finding did not reach statistical difference 
when twin pairs were analysed as a cluster unit. 
Inpatient monitoring usually started at about 26 weeks gestation, whereas monitoring was delayed 
until 30 weeks in the outpatient group. Our study showed that difference in fetal mortality between 
the inpatient and the outpatient group mainly resides in the 26-30 weeks window, and that once 
monitoring is instituted (be it in the inpatient or in the outpatient group) survival of monoamniotic 
twins is excellent, and outcomes of inpatient and outpatient groups are similar. Therefore, this study 
clearly showed that close monitoring is needed to achieve good outcomes in monoamniotic 
pregnancies regardless of the surveillance setting. 
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An important finding of this study is the markedly improved perinatal survival compared with older 
literature. This could be explained by the improved diagnosis and treatment but also by the fact that 
most losses in monoamniotic twin pregnancies are attributable to fetal abnormalities and 
spontaneous early miscarriage,
5
 which were excluded from our study. Therefore, these data may 
truly represent natural history of non-anomalous uncomplicated monoamniotic twins once viability 
has been reached.  
Our secondary analysis also showed that fetal death in non-anomalous uncomplicated 
monoamniotic twins occurred up to 31 6/7 weeks. Indeed, the major important and novel finding of 
the MONOMONO study was the lack of "late" gestational age deaths suggesting that advancing the 
planned timing of delivery from 32 to 34 6/7 weeks of gestational may be a safe approach for 
pregnant women with uncomplicated monoamniotic twin pregnancy. However, while no deaths 
occurred after 34 weeks, only 23 pregnancies continued beyond this gestation and hence the study 
was underpowered to make any conclusions on the optimal timing of delivery to avoid stillbirth. 
The most important limitation of our study was the retrospective non-randomized approach. 
Because of its retrospective nature, it was not possible to separate the importance of hospitalization 
versus the increased frequency of testing per se. Because this was not a randomized comparison, the 
findings were subject to bias. Moreover, since none of the institutions with the inpatient 
management performed continuous fetal heart rate monitoring, it was not possible to assess whether 
this monitoring approach can further decrease fetal deaths. Variations in management among the 
different institutions could have influenced our findings. Inpatient and outpatient management were 
highly dissimilar between the included centers, as reported in Table 1. Data on patient satisfaction, 
neonatal outcomes and economic implications were not available. 
Comparison with prior literature and implications 
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Several small studies evaluating perinatal outcomes in monoamniotic twins, have been published 
(Table S3).
21-27
 Heyborne et al. performed a retrospective study to assess the effectiveness of 
inpatient monitoring of monoamniotic twins. They observed improved neonatal survival among 
women who were admitted electively for inpatient monitoring.
21
 On the contrary, Van Mieghen et 
al.
23
 concluded that if close fetal surveillance is instituted after 26-28weeks and delivery takes place 
at approximately 32-34weeks, the risk of perinatal complications is low, no matter the surveillance 
setting. 
 
Fetal demise is a major concern as monoamniotic twins approach term, since early delivery would 
prevent this occurrence. It is indeed common for monoamniotic twins to be delivered preterm with 
planned cesarean delivery at about 32 weeks of gestations.
5,9
 In 2016, the Royal College of 
Obstetricians and Gynecologists (RCOG), ACOG, and SMFM recommended that monoamniotic 
twin pregnancies should be delivered by cesarean delivery between 32 and 33 weeks due to the high 
risk of intrauterine fetal death.
9,28
  These recommendations are based on studies demonstrating that 
the perinatal mortality doubles beyond 34 weeks (7%) compared with 33 weeks (4%).
4 
However, 
the justification of preterm delivery should be balanced against the likelihood of respiratory distress 
syndrome (5%) at 32 weeks
1,7
 despite the use of antenatal steroids
29-31
 in otherwise uncomplicated 
pregnancies.
1,3,8,9
 This balance may not be achieved if fetal losses in uncomplicated monoamniotic 
twins are low.
1,4
 Our study showed no fetal or neonatal death after 31 6/7 weeks and up to 36 6/7 
weeks.  
Conclusions 
In summary, in uncomplicated monoamniotic twins, when compared with outpatient management, 
inpatient surveillance is associated with similar fetal mortality. As the raw rates of fetal mortality 
were 3.3% in the inpatient group and 10.8% in the outpatient group, further research is necessary 
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Our data also suggest that in case of non-anomalous uncomplicated monoamniotic twins the fetal 
and neonatal death rate does not increase after 32 0/7 weeks, and therefore planned cesarean 
delivery 33 0/6 – 34 6/7 is a reasonable alternative to discuss with the patient. The data after 34 
weeks are too limited to make a recommendation.Due to the retrospective nature of this study, large 
practice changes should be employed with caution. Although a randomized controlled trial would 
provide the best evidence of the preferable method of monitoring for monoamniotic twins, this 
would be logistically difficulty given the rarity of such pregnancies.  
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FIGURES 
 
Figure 1. Study flow chart. STROBE template 
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TABLES 1 
 2 
Table 1. Management protocol in the included centers 3 
 4 
Centers Inpatient protocol Outpatient protocol Planned cesarean delivery 
(weeks) 
CENTERS WITH OUTPATIENT MANAGEMENT 
Naples, Italy - US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
32 0/7 – 34 6/7 
Florence, Italy - US fetal growth every 2 weeks; 
US Doppler every 1 week; only one 
CCTG the day before the planned 
cesarean delivery 
32 0/7 – 33 6/7 
Chieti, Italy - US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
32 0/7 – 33 6/7 
Padova, Italy - US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
32 0/7 – 35 6/7 
Udine, Italy - US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
32 0/7 – 33 6/7 
Catanzaro, Italy - US fetal growth every 4 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
33 0/7 – 36 6/7 
Rome Tor Vergata, 
Italy 
- US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
32 0/7 – 32 6/7 
Rome Sapienza, 
Italy 
- US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
33 0/7 – 33 6/7 
Buzzi Children’s - US fetal growth and Doppler every 2 32 0/7 – 32 6/7 
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Hospital, Milan, 
Italy 
weeks from 16 to 24 weeks and then 
weekly  
 
Ciudad Real, Spain - US fetal growth every 3 weeks; 
US Doppler every 2 weeks; only one 
CCTG the day before the planned 
cesarean delivery 
32 0/7 – 32 6/7 
Madrid, Spain - US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
33 0/7 – 34 6/7 
UCLH London, UK - US fetal growth every 2 weeks; 
US Doppler every 2 weeks; 
CCTG once a week starting from 30 
0/7 weeks 
32 0/7 – 35 0/7 
CENTERS WITH INPATIENT MANAGEMENT 
Treviso, Italy Admission between 27 0/7 – 27 6/7 weeks; 
US fetal growth every 2 weeks; 
US Doppler every week; 
CCTG one or two times a day 
- 32 0/7 – 32 6/7 
Bologna, Italy Admission between 27 0/7 – 27 6/7 weeks; 
US fetal growth every 2 weeks; 
US Doppler every week; 
CCTG one or two times a day 
- 32 0/7 – 33 6/7 
Parma, Italy Admission between 24 0/7 – 24 6/7 weeks; 
US fetal growth every 2 weeks; 
US Doppler twice a week; 
NST twice a day 
- 32 0/7 – 32 6/7 
Brescia, Italy Admission between 28 0/7 – 28 6/7 weeks; 
US fetal growth every 2 weeks; 
- 32 0/7 – 32 6/7 
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US Doppler every week; 
CCTG two times a day 
Turin, Italy Admission between 28 0/7 – 29 0/7 weeks; 
US fetal growth every 2 weeks; 
US Doppler 2 times a week; 
CCTG two or three times a day 
- 32 0/7 – 33 0/7 
Thomas Jefferson 
University, USA 
Admission between 26 0/7 – 27 6/7 weeks; 
US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
NST three times a day 
- 32 0/7 – 33 0/7 
Johns Hopkins 
Hospital, USA 
Admission between 26 0/7 – 27 6/7 weeks; 
US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
NST three times a day 
- 32 0/7 – 33 0/7 
University of 
Massachussets-
Baystate, USA 
Admission between 26 0/7 – 27 6/7 weeks; 
US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
NST three times a day 
- 32 0/7 – 32 6/7 
Baylor College of 
Medicine, USA 
Admission between 26 0/7 – 27 6/7 weeks; 
US fetal growth every 3 weeks; 
US Doppler every 2 weeks; 
NST three times a day 
- 32 0/7 – 34 6/7 
Oviedo, Spain Admission between 27 0/7 – 27 6/7 weeks; 
US fetal growth every 2 weeks; 
US Doppler every 2 weeks; 
NST twice a day 
- 32 0/7 – 34 6/7 
US, ultrasound; CCTG, computerized cardiotocography; NST, nonstress test. Ultrasound fetal growth included fetal biometry for both twins, and amniotic fluid volume with 5 
deepest vertical pocket. Ultrasound Doppler included umbilical artery Doppler, and middle cerebral artery peak systolic velocity, for both twins. 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
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Table 2. Characteristics of the included monoamniotic twin gestations 16 
 17 
 Inpatient management 
N = 75 women (38.5%) 
Outpatient management  
N = 120 women (61.5%) 
P value 
Age (years)  Mean±SD 28.8±5.5 30.0±4.3 0.12 
ART  5 (6.7%) 10 (8.3%) 0.88 
BMI (kg/m
2
) Mean±SD 25.5±5.3 26.2±5.5 0.40 
Smoking during pregnancy 9 (12.0%) 11 (9.2%) 0.71 
Ethnicity 
     White  
     African American  
     Other* 
 
59 (78.7%) 
6 (8.0%) 
10 (13.3%) 
 
107 (89.2%) 
6 (5.0%) 
7 (5.8%) 
0.12 
Gravidity 
     Median (range) 
 
2 (1-8) 
 
2 (1-7) 
 
0.54 
Parity 
     Median (range) 
 
1 (0-4) 
 
1.5 (0-4) 
 
0.77 
Prior stillbirth 
      
 
1 (1.3%) 
 
1 (0.8%) 0.99 
ART, assisted reproductive technology; SD, standard deviation. Data are presented as number (percentage) or as mean ± standard deviation or as median (range).  18 
* Other, including Asian and Hispanic 19 
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Table 3. Primary and secondary outcomes 20 
 21 
 Inpatient 
management 
N = 75 women 
Outpatient 
management  
N = 120 women 
MD (95% CI) OR (95% CI) P value 
Maternal outcomes 
Gestational age at delivery (weeks) 31.6±1.7 31.5±2.4 -0.10 week (-0.48 to 
0.68) 
- 0.64 
Maternal LOS (days) 42.1±14.5 7.4±3.4 34.70 days (31.36 to 
38.04) 
- <0.01 
Fetal and neonatal outcomes 
 Inpatient 
management 
N = 150 fetuses 
Outpatient 
management  
N = 240 fetuses 
MD (95% CI) OR (95% CI) P value 
Intrauterine fetal death** 5 (3.3%) 26 (10.8%) - 0.28 (0.11 to 0.76) 0.01 
Neonatal death 1 (0.7%) 10 (4.2%) - 0.15 (0.02 to 1.22) 0.08 
Perinatal death 6 (4.0%) 36 (15.0%) - 0.24 (0.10 to 0.58) <0.01 
Neonatal outcomes based on live-born babies only* 
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 Inpatient 
management** 
N = 145 fetuses 
Outpatient 
management **  
N = 214 fetuses 
MD (95% CI)* OR (95% CI) P value 
Birth weight (grams)* 1,646±343 1,616±411 30.00 grams (-48.42 to 
108.42) 
- 0.45 
LOS in NICU (days)* 24.3±18.4 40.2±52.5 -15.90 days (-23.55 to -
8.25) 
- <0.01 
Neonatal mortality in live-born only* 1 (0.7%) 10 (4.7%) - 0.15 (0.02 to 1.22) 0.08 
Data are presented as number (percentage) or as mean ± standard deviation  22 
Boldface data, statistically significant 23 
OR, odds ratio; CI, confidence interval; MD, mean difference; LOS, length of stay; NICU, neonatal intensive care unit  24 
*Outcomes based on live-born babies only 25 
**Primary outcome of the study 26 
27 
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Table 4. Potential predictors of intrauterine fetal death (n=31).  28 
 29 
 OR (95% CI) p * 
   
Inpatient vs outpatient management 0.21 (0.04-1.17) 0.07 
Gestational age, 1-week increase 0.55 (0.36-0.89) 0.006 
Birthweight discordance , 1% increase 1.03 (0.93-1.14) 0.6 
   
OR, odds ratio; CI, confidence interval 30 
* Generalized mixed model analysis, using twin pair as the cluster unit. 31 
 32 
 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
 51 
 52 
 53 
 54 
 55 
Page 31 of 37
John Wiley & Sons, Ltd.
Ultrasound in Obstetrics and Gynecology
For Peer Review
30 
 
Table 5. Indication for delivery  56 
 57 
 Inpatient management 
N = 75 women 
Outpatient management  
N = 120 women 
OR (95% CI) P value 
Maternal indication 
 
1 (1.3%)* 6 (5.0%)** 0.26 (0.03 to 2.18) 0.21 
Fetal indication 11 (14.7%) 8 (6.7%) 2.41 (0.92 to 6.29) 0.07 
Planned scheduled delivery 53 (70.7%) 82 (68.3%) 1.12 (0.60 to 2.09) 0.73 
Spontaneous onset of labor before 
planned delivery 
10 (13.3%) 24 (20.0%) 0.62 (0.28 to 1.37) 0.24 
Data are presented as number (percentage) OR, odds ratio; CI, confidence interval 58 
*One case of preeclampsia 59 
**Three cases of preeclampsia; two cases of placental abruption 60 
61 
Page 32 of 37
John Wiley & Sons, Ltd.
Ultrasound in Obstetrics and Gynecology
For Peer Review
31 
 
Table 6. Details of intrauterine fetal deaths according to gestational age 62 
 63 
Details of intrauterine fetal deaths according to gestational age for each fetuses  
 Overall 
N=195 women, 390 fetuses 
Inpatient management 
N = 75 women, 150 fetuses 
Details of intrauterine fetal 
deaths in the inpatient 
group 
Outpatient 
management  
N = 120 women, 240 
fetuses 
Details of intrauterine fetal 
deaths in the outpatient group 
27 0/7 – 27 6/7* 
 
5/390 (1.3%) 1/150 (0.7%) 1 single death 4/240 (1.7%) 2 double deaths 
28 0/7 – 28 6/7* 6/368 (1.6%) 0/148 (0%) - 6/220 (2.7%) 2 double deaths 
2 single deaths 
29 0/7 – 29 6/7* 15/348 (4.3%) 3/148 (2.0%) 1 single death 
1 double death 
12/200 (6.0%) 5 double deaths 
2 single deaths 
30 0/7 – 30 6/7* 3/299 (1.0%) 1/135 (0.7%) 1 single death 2/164 (1.2%) 1 double death 
31 0/7 – 31 6/7* 2/278 (0.7%) 0/120 (0%) - 2/158 (1.3%) 1 double death 
32 0/7 – 32 6/7* 0/240 (0%) 0/100 (0%) - 0/140 (0%) - 
33 0/7 – 33 6/7* 0/134 (0%) 0/34 (0%) - 0/100 (0%) - 
34 0/7 – 34 6/7* 0/46 (0%) 0/10 (0%) - 0/36 (0%) - 
35 0/7 – 35 6/7* 0/20 (0%) 0/0 - 0/20 (0%) - 
36 0/7 – 36 6/7* 0/10 (0%) 0/0 - 0/10 (0%) - 
Overall intrauterine 
fetal death 
31/390 (7.9%) 5/150 (3.3%) 3 single deaths 
1 double death 
26/240 (10.8%) 4 single deaths 
11 double deaths 
Details of intrauterine fetal deaths according to gestational age for each woman  
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Overall women who 
experienced 
intrauterine fetal 
death 
19/195 (9.7%) 4/75 (5.3%) - 15/120 (12.5%) - 
Data are presented as number (percentage) OR, odds ratio; CI, confidence interval 64 
*Denominator includes total numbers of alive fetuses at that gestational age (therefore excluded fetal death and delivered babies) 65 
**Denominator refers to numbers of pregnant woman  66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
 75 
 76 
 77 
 78 
 79 
 80 
 81 
 82 
 83 
 84 
 85 
 86 
 87 
 88 
 89 
 90 
 91 
 92 
 93 
 94 
 95 
 96 
 97 
 98 
 99 
 100 
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392 pregnancies with confirmed 
monoamnionicity from 22 University 
Hospitals screened for eligibility 
197 pregnancies excluded: 
- One or borth fetal death <26 weeks 
(n=44) 
- Induced termination of pregnancy 
(n=17) 
- Major fetal abnormalities (n =25) 
- IUGR (n=67) 
- Pseudoamnionicity (n=1) 
- TTTS or TRAP (n=37) 
- Selective reduction from triplets (n=6) 
195 non-anomalous uncomplicated women 
with monoamniotic twin pregnancies (390 
fetuses) included in the analysis 
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SUPPLEMENTARY TABLES 
 
Table S1. Details of neonatal deaths according to gestational age at delivery 
 
Gestational age at delivery Overall 
N=195 women, 390 fetuses 
Inpatient management 
N = 75 women, 150 fetuses 
Outpatient management  
N = 120 women, 240 fetuses 
27 0/7 – 27 6/7* 
 
10/390 (2.6%) 0/150 (0%) 10/240 (4.2%)     
28 0/7 – 28 6/7* 0/368 (0%)  0/148 (0%) 0/220 (0%)  
29 0/7 – 29 6/7* 0/368 (0%) 0/148 (0%) 0/200 (0%) 
30 0/7 – 30 6/7* 0/299 (0%) 0/135 (0%) 0/164 (0%) 
31 0/7 – 31 6/7* 1/278 (0.4%) 1/120 (0.8%) 0/158 (0%) 
32 0/7 – 32 6/7* 0/240 (0%) 0/100 (0%) 0/140 (0%) 
33 0/7 – 33 6/7* 0/134 (0%) 0/34 (0%) 0/100 (0%) 
34 0/7 – 34 6/7* 0/46 (0%) 0/10 (0%) 0/36 (0%) 
35 0/7 – 35 6/7* 0/20 (0%) 0/0 0/20 (0%) 
36 0/7 – 36 6/7* 0/10 (0%) 0/0 0/10 (0%) 
Overall neonatal death 11/390 (2.8%) 1/150 (0.7%)   10/240 (4.2%) 
Data are presented as number (percentage) OR, odds ratio; CI, confidence interval 
*Denominator includes total numbers of alive fetuses at that gestational age (therefore excluded fetal death and delivered babies) 
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Table S2. Details of perinatal deaths according to gestational age at delivery 
 
Gestational age at delivery Overall 
N=195 women, 390 fetuses 
Inpatient management 
N = 75 women, 150 fetuses 
Outpatient management  
N = 120 women, 240 fetuses 
27 0/7 – 27 6/7* 
 
15/390 (1.3%) 1/150 (0.7%) 14/240 (5.8%)     
28 0/7 – 28 6/7* 6/368 (1.6%) 0/148 (0%) 6/220 (2.7%)     
29 0/7 – 29 6/7* 15/348 (4.3%) 3/148 (2.0%) 12/200 (6.0%) 
30 0/7 – 30 6/7* 3/299 (1.0%) 1/135 (0.7%) 2/164 (1.2%) 
31 0/7 – 31 6/7* 3/278 (0.7%) 1/120 (0.8%) 2/158 (1.3%) 
32 0/7 – 32 6/7* 0/240 (0%) 0/100 (0%) 0/140 (0%) 
33 0/7 – 33 6/7* 0/134 (0%) 0/34 (0%) 0/100 (0%) 
34 0/7 – 34 6/7* 0/46 (0%) 0/10 (0%) 0/36 (0%) 
35 0/7 – 35 6/7* 0/20 (0%) 0/0 0/20 (0%) 
36 0/7 – 36 6/7* 0/10 (0%) 0/0 0/10 (0%) 
Overall perinatal death 42/390 (10.8%) 6/150 (4.0%) 36/240 (15.0%) 
 
Data are presented as number (percentage) OR, odds ratio; CI, confidence interval 
*Denominator includes total numbers of alive fetuses at that gestational age (therefore excluded fetal death and delivered babies) 
 
Table S3. Fetal death rates with inpatient and outpatient care, studies published since 2005 
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 Number of pregnant 
women with non-
anomalous twin 
gestations who 
reached viability 
Intrauterine fetal 
deaths inpatient* 
Intrauterine fetal 
deaths outpatient* 
Inpatient protocol Outpatient protocol 
Heyborne 2005
21 87 0/86 13/88 Admission between 26 0/7 – 27 6/7 
weeks; 
NST 2-3 times a day  
NST 1-3 times a week  
Ezra 2005
7 
**
 10 0/20 - Admission after 25 weeks; 
NST 3 times a day; 
US fetal growth every 2 weeks; 
Biophysical profile and US Doppler 
twice weekly 
- 
Defalco 2006
22 23 0/22 3/24 Admission between 24 0/7 – 28 6/7 
weeks;  
US fetal growth and Doppler every 4 
weeks; 
Continuous fetal monitoring 
NST and biophysical 
profile at least three 
times per week 
Pasquini 2006
26 
***
 20 - 0/40 - Prophylactic maternal 
sulindac from 20-22 
weeks; 
US fetal growth and 
Doppler every 2 
weeks 
Quinn 2011
25 
**
 17 0/34 - Admission at 24 weeks; 
Continuous fetal monitoring 
- 
Murata 2013
24 27 1/52 0/2 Admission between 24 0/7 – 26 6/7 
weeks;  
US at least once a week; 
NST at least once a day 
Not reported 
Van Mieghem 2014
23 124 2/142 5/106 Admission between 26 0/7 – 28 6/7 
weeks; 
US every 2 days; 
NST 2-3 times a day  
NST once a week 
US once a week 
Prefumo 2015
27
 ** 10 2/20 - Admission between 28 0/7 – 28 6/7 
weeks;  
US fetal growth every 2 weeks; 
US Doppler twice weekly; 
- 
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CCTG two times a day  
Total (%) 318 5/376 (1.3%) 21/260 (8.1%) - - 
*Excluding spontaneous miscarriage <24 weeks, and induced termination of pregnancy. Denominator includes only non-anomalous fetuses who reached viability 
**All women managed inpatient ***All women managed outpatient 
NST, nonstress test; CCTG, computerized cardiotocography; US, ultrasound 
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